- Home
- Pharmaceutical Partners
查找地点
有关时间、上门服务和预约Innovative Biomarker Testing
including pTau217, GFAP, NfL and Aβ 42/40
Deep Therapeutic Expertise
across neurodegenerative diseases like Alzheimer's, Parkinson's and more
Comprehensive Clinical Trial Testing
from biomarker discovery to companion diagnostic commercialization
Biomarker | Associated Diseases | ||||||||||
NfL | Neurodegeneration: MS, ALS, AD, PD, FTD (frontotemporal dementia), HAND (HIV associated neurocognitive disorder), COVID-19 associated neurological disorders, concussion/mTBI | ||||||||||
GFAP | Neurodegeneration: MS, AD, NMOSD (neuromyelitis optica spectrum disorder), COVID-19 associated neurological disorders, concussion/mTBI | ||||||||||
pTau217 | AD | ||||||||||
pTau181 | AD | ||||||||||
Total tau | Tauopathies: AD, FTD with Parkinsons (PD), PSP (progressive supranuclear palsy), HAND, concussion/mTBI | ||||||||||
Neuro 3-plex: Amyloid beta (1-42), Amyloid beta (1-40), total tau | AD, HAND | ||||||||||
Neuro 4-plex E: Amyloid beta (1-42), Amyloid beta (1-40), NfL and GFAP | AD | ||||||||||
Neuro 4-plex A: NfL, GFAP, Total Tau, UCH-L1 | Concussion/mTBI | ||||||||||
a-synuclein | PD, AD | ||||||||||
Amyloid beta (1-40) | AD | ||||||||||
Amyloid beta (1-42) | AD | ||||||||||
Amyloid beta 42/40 | AD | ||||||||||
pTau231 | AD | ||||||||||
Cytokine 3-plex: IL-6, TNFa, IL-10 | AD (inflammation) |
Check out our Alzheimer’s-specific biomarker offerings.
Leverage Labcorp’s deep knowledge supporting 90+ Alzheimer’s disease protocols–in 45+ countries with 96,000+ patients–in the last 5 years alone
Access holistic and specialized neurology expertise for support from strategy to lab with our Biomarker Solution Center and global translational biomarker scientists
Experience Alzheimer's clinical trial testing delivered by a global laboratory network with critical sample management and logistics capabilities